5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl beta-D-glucopyranoside(CAS: 529-55-5)

Regulatory guidelines for 5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl beta-D-glucopyranoside (CAS: 529-55-5) include GHS classification, REACH regulations, and FDA/EPA requirements. It is classified as a hazardous substance based on its chemical structure and potential health and environmental impacts. Compliance with these regulations is essential for safe handling, transportation, and disposal.

Alternatives to 5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl beta-D-glucopyranoside (CAS: 529-55-5) in synthesis include various analogs, such as 7-O-glucosylkaempferol, which can serve as a structurally similar compound. Other substitutes include using isomers or different reagents depending on the specific application and reactivity requirements.

The market for 5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl beta-D-glucopyranoside (CAS: 529-55-5) is growing due to its potential in pharmaceutical and natural product research. Research trends are focused on its antioxidant and anti-inflammatory properties. Market trends show increasing demand in the health and wellness industry, alongside advancements in synthetic methodologies for improved production efficiency.

Waste containing 5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl beta-D-glucopyranoside (CAS: 529-55-5) should be collected in designated containers, properly labeled, and stored in a secure location. Incineration or professional waste disposal is recommended for safe disposal. Environmental precautions include ensuring no spills and implementing adequate ventilation to prevent exposure and environmental contamination. Compliance with local waste management regulations is crucial.